Target intelligence / Profile preview

Lipid Bilayers and Metabolic Enzymes

Molecular classification
Enzyme, Other
01

Overview

Lipid Bilayers and Metabolic Enzymes represents a broad physiological system rather than a discrete therapeutic target. Lipid bilayers serve as the primary structural component of biological membranes, providing a hydrophobic barrier that compartmentalizes cellular processes and hosts membrane-bound proteins (Alberts et al., 2002). Metabolic enzymes constitute a vast class of proteins that catalyze the chemical transformations necessary for energy production, biosynthesis, and detoxification (Moran et al., 2012). While specific enzymes within this category, such as HMG-CoA reductase or Cytochrome P450, are major targets for drugs like statins and various small molecules, the collective term is too heterogeneous for specific drug development (DrugBank). Therapeutic interventions involving these components often aim to modulate metabolic flux or alter membrane permeability, as seen with antifungal agents that target membrane sterols (NCBI). Due to the ubiquity and diversity of these entities, they are classified as a biological system or environment rather than a single target molecule.

Other names
Biological membranes and metabolic proteinsMembrane-associated metabolic enzymesCellular lipid membranes and metabolic catalysts
02

Mechanism of action

Inhibition of specific metabolic pathways or alteration of membrane permeability and integrity.

03

Biological functions

MetabolismCellular compartmentalizationSignal transductionEnergy productionMembrane transport
04

Disease associations

Metabolic disorderCancerCardiovascular diseaseNeurodegenerative disease
05

Safety considerations

Systemic toxicityOff-target metabolic disruptionMembrane instabilityDisruption of essential homeostasis
06

Interacting drugs

Statins

4 more in the full profile.

07

Biomarkers

Serum lipid levelsBlood glucoseMetabolite concentrationsEnzyme activity assays

Beyond the preview

Go deeper on Lipid Bilayers and Metabolic Enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lipid Bilayers and Metabolic Enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call